Shi Mengran, Shen Zongyi, Zhang Nan, Wang Luyao, Yu Changyuan, Yang Zhao
College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
College of Life Science, Engineering Laboratory of South Xinjiang Chemical Resources Utilization of Xinjiang Production and Construction Corps, Tarim University, Alar 843300, Xinjiang, China.
Sheng Wu Gong Cheng Xue Bao. 2021 Apr 25;37(4):1205-1228. doi: 10.13345/j.cjb.200401.
Genome editing is a genetic manipulation technique that can modify DNA sequences at the genome level, including insertion, knockout, replacement and point mutation of specific DNA fragments. The ultimate principle of genome editing technology relying on engineered nucleases is to generate double-stranded DNA breaks at specific locations in genome and then repair them through non-homologous end joining or homologous recombination. With the intensive study of these nucleases, genome editing technology develops rapidly. The most used nucleases include meganucleases, zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats associated Cas proteins. Based on introducing the development and principles of above mentioned genome editing technologies, we review the research progress of CRISPR/Cas9 system in the application fields of identification of gene function, establishment of disease model, gene therapy, immunotherapy and its prospect.
基因组编辑是一种基因操作技术,可在基因组水平上修饰DNA序列,包括特定DNA片段的插入、敲除、替换和点突变。依赖于工程核酸酶的基因组编辑技术的基本原理是在基因组中的特定位置产生双链DNA断裂,然后通过非同源末端连接或同源重组进行修复。随着对这些核酸酶的深入研究,基因组编辑技术迅速发展。最常用的核酸酶包括大范围核酸酶、锌指核酸酶、转录激活样效应物核酸酶以及成簇规律间隔短回文重复序列相关的Cas蛋白。在介绍上述基因组编辑技术的发展和原理的基础上,我们综述了CRISPR/Cas9系统在基因功能鉴定、疾病模型建立、基因治疗、免疫治疗应用领域的研究进展及其前景。